High Potency Active Pharmaceutical Ingredients (APIs) Market Recent Trends, Analysis And Forecast 2025 | Grand View Research Inc.
“The global high potency active pharmaceutical ingredients (APIs) market was valued at USD 14.4 billion in 2016 and is expected to grow at a CAGR of 10.3% over the forecast period.”
Global HPAPIs market is expected to reach USD 34.8 billion by 2025, according to a new report by Grand View Research, Inc. Increasing number of new entrants producing fast relief therapeutics in emerging countries of India and China is anticipated to boost the demand for High potency active pharmaceutical ingredients (HPAPIs) over the forecast period. In addition, supportive government regulations for commercialization and research and development of novel drug molecules are projected to drive the industry growth. Extensive capital investments required for development of production facility has lead to increase in contract manufacturing activities for HPAPIs during the forecast period.
Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/high-potency-activepharmaceutical-ingredients-hpapi-market Further key findings from the study suggest:
Synthetic route of High PotencyAPIs dominated the overall market in terms of revenue share as of 2016 owing to presence of large manufacturers producing these type of molecules
Biotech HPAPI segment is expected to be the fastest growing and is expected to grow at a lucrative growth ratedue torising demand for cancer drugs and fueling research and developmentactivities pertaining to it
Innovative drug market dominated the overall drug type in 2016. Generic drug segment is expected to be the fastest growing segment. The factors attributing to its growth are patent expiration of various drugs and increasing demand for the cancer treatment
Follow Us: